Philips has launched its new EPIQ Elite ultrasound system, offering a range of diagnostic solutions for different medical specialties, including the company’s first for vascular assessments.
"With one in four stroke cases caused by vascular disease of the carotid artery in the neck, vascular health is a growing concern worldwide,” said Jeff Cohen, business leader of Philips’ general imaging and women's healthcare ultrasound divisions, describing ultrasound as the ideal imaging technology for a precise diagnosis.
Philips’ solution employs its xMATRIX linear transducer to produce 3D images of the patient’s vasculature, allowing clinicians to see into a vessel to evaluate plaque location and composition as well as flow data to assess stenotic conditions. The system also allows clinicians to acquire two planes simultaneously, which the company said improves accuracy and can reduce exam time by 20%.
"Our new portfolio of dedicated systems and solutions based on the EPIQ Elite combines new display technology, innovative transducers, advanced software and enhanced processing power," Cohen added.
In obstetrics and gynecology, Philips said the EPIQ Elite system provides lifelike 3D scans to offer improved detection of birth defects and potential complications during all stages of pregnancy. The system, along with Philips’ TrueVue technology, allows the clinician to move a virtual light source around the 3D images of the fetus to provide high levels of detail.
RELATED: Special Report—The top 10 medtech companies of 2024 | Philips
Late last year, Philips unveiled its first dedicated breast ultrasound solution, combining screening, elastography, precision biopsy and visual mapping tools, available with the Philips EPIQ and Affiniti systems.
It includes automated visual mapping and annotation software, to help provide full coverage of the breast during the acquisition procedure. Its elastography hardware also helps provide more information on the stiffness of breast tissue and creates a color-coded map of the results.